📣 Send us your press release
Site updates every 15 minutes
Health

Ardelyx Shares Decline After Q2 Revenue Misses Expectations

Ardelyx (NASDAQ: ARDX) shares closed down 17.86% on August 7, 2026, following Q2 product revenue that fell short of consensus. Analysts subsequently lowered their price targets for the stock.

14 August 2026
Ardelyx Shares Decline After Q2 Revenue Misses Expectations

Ardelyx (NASDAQ: ARDX) saw its stock price fall significantly, closing at $4.00 on August 7, 2026, representing a 17.86% decrease. The decline followed the company's second-quarter financial report, which revealed product revenue below market expectations.

The company reported $118.1 million in product revenue for the second quarter, failing to meet analyst consensus estimates. In response to the weaker-than-expected results, several financial analysts adjusted their price targets downwards for Ardelyx shares.

This development has also attracted the attention of legal representatives. The law firm Levi & Korsinsky has announced that it is initiating an investigation into Ardelyx (ARDX). The investigation is expected to examine the company's potential liabilities towards its investors.

Original source: prnewswire.com